ABCG2 and cancer: ABC transporter inhibitors, including inhibitors of Pgp, BCRP, and MRP, increase the efficacy of anti-cancer treatments and have the potential to serve as an adjuvant to cancer chemotherapy (Pena-Solorzano et al., 2017; Li et al., 2023).